Advertisement
Telemedicine can be beneficial

ACP Supports Expanded Role of Telemedicine for Health Care

0
Responsible telemedicine can take place when a physician-patient relationship has been established
Among electronic health record products

EHR Vendors Not Adhering to Usability Certification Standards

0
Several widely used EHR products found not to adhere to ONC certification requirements
An accelerated baccalaureate/doctor of medicine program does not impair the academic performance of medical students

Accelerated MD Program Doesn’t Mar Academic Performance

0
Academic performance of students is comparable in accelerated program, conventional MD program
In a review article published online Sept. 3 in the New England Journal of Medicine

Suggested Response Provided for In-Flight Medical Emergencies

0
Article offers tips for physicians providing emergency in-flight medical care
For patients with diabetic nephropathy receiving an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker

Finerenone Linked to Improved UACR in Diabetic Nephropathy

0
Addition of finerenone to ACE inhibitor or ARB tied to reduction in urinary albumin-creatinine ratio

August 2015 Briefing – Nephrology

0
Here are what the editors at HealthDay consider to be the most important developments in Nephrology for August 2015. This roundup includes the latest...
Nonalbuminuric chronic kidney disease is associated with increased risk of cardiovascular disease and all-cause mortality

Nonalbuminuric CKD Ups Cardiovascular Morbidity in T1DM

0
Also linked to increase in all-cause mortality, but not albuminuria or end-stage renal disease
The outcome of a recent case regarding the termination of physicians by an insurance company following a dispute over the necessity of medical services provided has serious implications for physicians and their patients

AMA: Ruling Makes It Easier for Insurers to Terminate Doctors

0
Court supported insurance company in termination of doctors after dispute over necessity of services
A proposal for identifying lower-cost generic biotech drugs has been released by the U.S. Food and Drug Administration.

FDA Issues Proposal on Lower-Cost, Generic Biotech Drugs

0
All biotech drugs to carry a four-letter code to distinguish brand name, generic versions
Too few members of certain minority groups are pursuing careers in U.S. medicine

Too Few Blacks, Hispanics Pursuing Careers As Physicians

0
Shortage of minority physicians may affect U.S. patient care, experts say